title: How possible is the development of an operational psychometric method to assess the presence of the 5-HTTLPR s allele? Equivocal preliminary findings.
abstract: OBJECTIVE
  The s allele of the 5-hydroxytryptamine transporter-linked promoter region (5-HTTLPR) polymorphism of the serotonin transporter gene has been found to be associated with neuroticism-related traits, affective temperaments and response to selective serotonin reuptake inhibitor (SSRI) treatment. The aim of the current study was to develop a psychometric tool that could at least partially substitute for laboratory testing and could predict the presence of the s allele.
  
  
  METHODS
  The study included 138 women of Caucasian origin, mean 32.20 +/- 1.02 years old. All subjects completed the Hungarian standardised version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire (TEMPS-A) instrument and were genotyped for 5-HTTLPR using PCR. The statistical analysis included the calculation of the Index of Discrimination (D), Discriminant Function Analysis, creation of scales on the basis of the above and then item analysis and calculation of sensitivity and specificity.
  
  
  RESULTS
  Four indices were eventually developed, but their psychometric properties were relatively poor and their joint application did not improve the outcome.
  
  
  CONCLUSIONS
  We could not create a scale that predicts the 5-HTTLPR genotype with sufficient sensitivity and specificity, therefore we could not substitute a psychometric scale for laboratory genetic testing in predicting genotype, and also possibly affective disorder characterisation and treatment.
authors.affiliation: Department of Pharmacodynamics, Semmelweis University, Faculty of Medicine, Budapest, Hungary. kendermagos@yahoo.com
authors.forename: Xenia
authors.initials: X
authors.lastname: Gonda
authors.forename: Konstantinos N
authors.initials: KN
authors.lastname: Fountoulakis
authors.forename: Zoltan
authors.initials: Z
authors.lastname: Rihmer
authors.forename: Andras
authors.initials: A
authors.lastname: Laszik
authors.forename: Hagop S
authors.initials: HS
authors.lastname: Akiskal
authors.forename: Gyorgy
authors.initials: G
authors.lastname: Bagdy
references.citation: J Affect Disord. 2005 Aug;87(2-3):291-7
references.pmid: 16002148
references.citation: Neuropsychopharmacology. 2000 Nov;23(5):587-90
references.pmid: 11027924
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):85-9
references.pmid: 15108187
references.citation: Mol Psychiatry. 1996 Dec;1(6):453-60
references.pmid: 9154246
references.citation: Mol Psychiatry. 1998 Nov;3(6):508-11
references.pmid: 9857976
references.citation: Biol Psychiatry. 1999 Feb 1;45(3):368-70
references.pmid: 10023516
references.citation: Am J Med Genet. 2001 Jul 8;105(5):458-63
references.pmid: 11449399
references.citation: J Neurochem. 1996 Jun;66(6):2621-4
references.pmid: 8632190
references.citation: J Affect Disord. 2008 Feb;106(1-2):45-53
references.pmid: 17706791
references.citation: J Affect Disord. 2003 Jan;73(1-2):99-104
references.pmid: 12507742
references.citation: Arch Gen Psychiatry. 2004 Nov;61(11):1163-9
references.pmid: 15520364
references.citation: Neurosci Lett. 1998 Oct 23;255(3):143-6
references.pmid: 9832193
references.citation: J Affect Disord. 2005 Mar;85(1-2):1-2
references.pmid: 15780670
references.citation: Psychiatr Genet. 2008 Aug;18(4):184-90
references.pmid: 18628680
references.citation: Arch Gen Psychiatry. 1998 Oct;55(10):936-40
references.pmid: 9783565
references.citation: Can J Psychiatry. 2001 Feb;46(1):35-44
references.pmid: 11221488
references.citation: Biotechniques. 1991 Apr;10(4):506-13
references.pmid: 1867860
references.citation: Science. 1996 Nov 29;274(5292):1527-31
references.pmid: 8929413
references.citation: J Clin Psychopharmacol. 2000 Feb;20(1):105-7
references.pmid: 10653220
references.citation: Neurosci Lett. 2002 Dec 6;334(1):17-20
references.pmid: 12431765
references.citation: Psychiatr Genet. 2004 Sep;14(3):121-9
references.pmid: 15318024
references.citation: Arch Gen Psychiatry. 2006 Oct;63(10):1113-20
references.pmid: 17015813
references.citation: J Affect Disord. 2005 Mar;85(1-2):127-33
references.pmid: 15780683
references.citation: J Affect Disord. 2009 Jan;112(1-3):19-29
references.pmid: 18455241
references.citation: J Affect Disord. 2006 Apr;91(2-3):125-31
references.pmid: 16464506
references.citation: Biol Psychiatry. 2006 Jul 15;60(2):84-92
references.pmid: 16300747
references.citation: Psychiatr Hung. 2006;21(2):147-60
references.pmid: 16929079
references.citation: Mol Psychiatry. 2007 Mar;12(3):247-57
references.pmid: 17146470
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1062-73
references.pmid: 15951088